507P - Immune checkpoint inhibitors for patients acquired resistance to tyrosine kinase inhibitors with EGFR mutated non-small cell lung cancer: A multicenter retrospective study

Autor: Uenami, T., Mori, M., Shiroyama, T., Nagatomo, I., Ihara, S., Komuta, K., Suzuki, H., Hirashima, T., Kimura, M., Imamura, F.
Zdroj: In Annals of Oncology November 2019 30 Supplement 9:ix171-ix171
Databáze: ScienceDirect